ArticleInternational journal of clinical and experimental medicine2015
Drug-resistant gene of blaOXA-23, blaOXA-24, blaOXA-51 and blaOXA-58 in Acinetobacter baumannii.
Article in International journal of clinical and experimental medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
27 citing papers in PubMed, 1 synthesis or guideline pooled it, 48 citations in OpenAlex.
- Geographical mapping and temporal trends of Acinetobacter baumannii carbapenem resistance: A comprehensive meta-analysis.PloS one · 2024Pooled it
- Molecular and Structural Insights ofAntibiotics (Basel, Switzerland) · 2026Article
- Molecular characterization and genotypic diversity of extensively drug-resistant Acinetobacter baumannii from endotracheal aspirates in a pediatric intensive care unit in Sulaimani, Iraq.Molecular biology reports · 2026Article
- Multiplex PCR-Based Detection of Eight Carbapenemase Genes and Their Clinical Characteristics in Urinary Tract Infections.Antibiotics (Basel, Switzerland) · 2026Article
- Antimicrobial Resistance inPathogens (Basel, Switzerland) · 2026Article
- Distribution of antimicrobial resistance genes and virulence genes in different genotypes of Acinetobacter baumannii.BMC infectious diseases · 2025Article
- Incidence of drug resistance and expression ofIranian journal of microbiology · 2025Article
- Exploring the novel paper wasp (Parapolybia escalerae) honey for green synthesis of silver nanoparticles with antibacterial properties.Scientific reports · 2025Article
- Carbapenem resistance in gram-negative pathogens in an Iranian hospital: high prevalence of OXA-type carbapenemase genes.Clinical and experimental pediatrics · 2025Article
- Article
- Exploring microbial diversity and biosynthetic potential in zoo and wildlife animal microbiomes.Nature communications · 2024Article
- Draft genome sequence ofMicrobiology resource announcements · 2024Article
- Analysis of carbapenem-resistantInternational journal of molecular epidemiology and genetics · 2024Article
- The Silent Threat: Antimicrobial-Resistant Pathogens in Food-Producing Animals and Their Impact on Public Health.Microorganisms · 2023Review
- Article
- Antimicrobial Resistance in Romania: Updates on Gram-Negative ESCAPE Pathogens in the Clinical, Veterinary, and Aquatic Sectors.International journal of molecular sciences · 2023Review
- Prevalence and Characterization of Beta-Lactam and Carbapenem-Resistant Bacteria Isolated from Organic Fresh Produce Retailed in Eastern Spain.Antibiotics (Basel, Switzerland) · 2023Article
- Adsorptive removal of levofloxacin and antibiotic resistance genes from hospital wastewater by nano-zero-valent iron and nano-copper using kinetic studies and response surface methodology.Bioresources and bioprocessing · 2023Article
- Predominance of OXA-48 Carbapenemase-Producing Enterobacterales in a Moroccan Hospital.International journal of microbiology · 2023Article
- Prevalence of Antibiotic-Resistant Bacteria and Antibiotic-Resistant Genes and the Quantification of Antibiotics in Drinking Water Treatment Plants of Malaysia: Protocol for a Cross-sectional Study.JMIR research protocols · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We distinguished the four alleles of OXA subgroups from 339 strains of Acinetobacter baumannii using Polymerase Chain Reaction, and investigated distributions of OXA subgroups in clinical isolated strains. A total of 196 Acinetobacter baumannii were isolated from the Central Hospital of Zhumadian between 2010 and 2014. Amplification of OXA genes, blaOXA-23, blaOXA-24, blaOXA-51 and blaOXA-58, were performed by PCR. Patients with Acinetobacter baumannii were selected from ICU, pneumology, emergency and cerebral surgery, accounting for 33.67%, 17.86%, 16.33% and 32.14%, respectively. Most strains showed resistance to different classes of agents, especially in ceftazidime, piperacillin, cefepime, nitrofurantoin and ertapenem. Multiplex PCR results showed, out of the 339 isolated strains, 164 (48.38%) were blaOXA-51, 157 (46.31%) were blaOXA-23, 18 (5.31%) were blaOXA-58, and no strain for blaOXA-24. 143 (47.67%) strains of blaOXA-51, 143 (47.67%) strains of blaOXA-23, and 14 (4.66%) strains of blaOXA-58 showed multidrug-resistant. In conclusion, our study found that OXA-51 and OXA-23 were the main mechanisms of resistant or sensitivity to carbapenems.
Indexed as
Identifiers
26550338PMC4613023W2178115280What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.